...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: a new study that one researcher called "stunning."

The Phase 2 and 3 trial results will tell the story. If Apabetalone(a cardiovascular btd) demonstrates efficacy as a Covid-19 therapeutic, BP will be all over this. 

Share
New Message
Please login to post a reply